# Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer

> **NCT01673607** · PHASE2 · UNKNOWN · sponsor: **Poitiers University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Resectable Hepatic Metastases of Colorectal Cancer

## Interventions

- **PROCEDURE:** Biopsie liver

## Key facts

- **NCT ID:** NCT01673607
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01-11
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01673607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01673607, "Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01673607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*